Alzamend Neuro ALZN
NASDAQ ALZN
$1.31 -0.04 (-2.96%)
At close: Nov 11, 2026 · 4:00 PM EST

Alzamend Neuro (ALZN) Other Non-Current Liabilities (2020 - 2026)

Updated

Alzamend Neuro (ALZN) posted Other Non-Current Liabilities of $742,263 for fiscal Q3 2024 (quarter ended Jan 31, 2024).

Analysis

Alzamend Neuro (ALZN) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Alzamend Neuro 6.51 Mn -8.95 Mn -
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 1.08 Mn
Apr 30, 2025 2.68 Mn
Apr 30, 2024 2.64 Mn
Jan 31, 2024 742,263.00
Apr 30, 2023 2.28 Mn
Jul 31, 2022 10.15 Mn
Jan 31, 2022 8.83 Mn
Jul 31, 2021 8.83 Mn
Jan 31, 2021 6.77 Mn
Jul 31, 2020 6.65 Mn
API Access

Alzamend Neuro Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ALZN&period=max&api_key=YOUR_API_KEY